C.A. Tamminga
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 15
- Bipolar Disorder and Treatment 3
- Epilepsy research and treatment 3
- Attention Deficit Hyperactivity Disorder 3
-
- Neuroscience and Neuropharmacology Research 6
- Co-authors
- Robert R. Conley (5 shared papers)Rosalinda C. Roberts (4 shared papers)Brian Dean (1 shared paper)Kazuo Sakai (1 shared paper)Deanna L. Kelly (2 shared papers)Gunvant K. Thaker (6 shared papers)Osamu Shirakawa (2 shared papers)Charles M. Richardson (1 shared paper)
- Journals
- Schizophrenia Research (23 papers)American Journal of Psychiatry (10 papers)Biological Psychiatry (5 papers)European Neuropsychopharmacology (3 papers)Molecular Psychiatry (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
C.A. Tamminga
52 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Biological Psychiatry 134
- Psychiatry and Mental health 511
- Cellular and Molecular Neuroscience 475
- Behavioral Neuroscience 56
- Cognitive Neuroscience 268
Countries citing papers authored by C.A. Tamminga
This map shows the geographic impact of C.A. Tamminga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Tamminga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Tamminga more than expected).
Fields of papers citing papers by C.A. Tamminga
This network shows the impact of papers produced by C.A. Tamminga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Tamminga. The network helps show where C.A. Tamminga may publish in the future.
Co-authors
The 25 scholars most cited alongside C.A. Tamminga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 317 | |
| 2 | 1999 | 104 | |
| 3 | 2002 | 95 | |
| 4 | 1989 | 94 | |
| 5 | Gender and schizophrenia. | 1997 | 91 |
| 6 | 2018 | 74 | |
| 7 | 2015 | 72 | |
| 8 | 1997 | 68 | |
| 9 | 1999 | 66 | |
| 10 | 1994 | 55 | |
| 11 | 2000 | 55 | |
| 12 | 2013 | 50 | |
| 13 | 1997 | 46 | |
| 14 | 1999 | 39 | |
| 15 | 1992 | 38 | |
| 16 | 2009 | 33 | |
| 17 | 2018 | 22 | |
| 18 | 1996 | 22 | |
| 19 | 2012 | 16 | |
| 20 | 1995 | 15 |
About C.A. Tamminga
C.A. Tamminga is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Molecular Biology, Cognitive Neuroscience and Pharmacology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (15 papers), Neuroscience and Neuropharmacology Research (6 papers), Functional Brain Connectivity Studies (5 papers), Treatment of Major Depression (4 papers), Tryptophan and brain disorders (4 papers), Bipolar Disorder and Treatment (3 papers), Epilepsy research and treatment (3 papers) and Attention Deficit Hyperactivity Disorder (3 papers). The work is most often cited by research in Biological Psychiatry (134 citations), Psychiatry and Mental health (511 citations), Cellular and Molecular Neuroscience (475 citations), Behavioral Neuroscience (56 citations) and Cognitive Neuroscience (268 citations). C.A. Tamminga has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Robert R. Conley, Rosalinda C. Roberts, Brian Dean, Kazuo Sakai, Deanna L. Kelly, Gunvant K. Thaker, Osamu Shirakawa, Charles M. Richardson, Adrienne C. Lahti and Yogesh Dwivedi. Their work appears in journals such as Schizophrenia Research, American Journal of Psychiatry, Biological Psychiatry, European Neuropsychopharmacology and Molecular Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.